. 2019 Dec;6(4).
doi: 10.2217/mmt-2019-0016.

Prognostic gene expression profiling in melanoma: necessary steps to incorporate into clinical practice

Douglas Grossman 1 Caroline C Kim 2 Rebecca I Hartman 3 Elizabeth Berry 4 Kelly C Nelson 5 Nwanneka Okwundu 1 Clara Curiel-Lewandrowski 6 Sancy A Leachman 4 Susan M Swetter 7 
  • PMID: 31871621
  •     39 References
  •     5 citations


Prognostic gene expression profiling (GEP) tests for cutaneous melanoma (CM) are not recommended in current guidelines outside of a clinical trial. However, their use is becoming more prevalent and some practitioners are using GEP tests to guide patient management. Thus, there is an urgent need to bridge this gap between test usage and clinical guideline recommendations by obtaining high-quality evidence to guide us toward best practice use of GEP testing in CM patients. We focus here on the opportunities and uncertainties associated with prognostic GEP testing in CM, review how GEP testing was incorporated into clinical care guidelines for uveal melanoma and breast cancer and discuss the role of clinical trials to determine best use in patients with CM.

Keywords: gene expression profile; melanoma; molecular testing.

Guidance of sentinel lymph node biopsy decisions in patients with T1-T2 melanoma using gene expression profiling.
John T Vetto, Eddy C Hsueh, +12 authors, Martin D Fleming.
Future Oncol, 2019 Jan 30; 15(11). PMID: 30691297
Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm.
U Veronesi, N Cascinelli, +7 authors, J C Durand.
N Engl J Med, 1988 May 05; 318(18). PMID: 3079582
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, +12 authors, Norman Wolmark.
N Engl J Med, 2004 Dec 14; 351(27). PMID: 15591335
Highly Cited.
Risk Factors for Lymphatic and Hematogenous Dissemination in Patients With Stages I to II Cutaneous Melanoma.
Laura Calomarde-Rees, Rosario García-Calatayud, +6 authors, Eduardo Nagore.
JAMA Dermatol, 2019 May 02; 155(6). PMID: 31042264    Free PMC article.
Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues.
Jochen Jaeger, Dirk Koczan, +4 authors, Manfred Kunz.
Clin Cancer Res, 2007 Feb 10; 13(3). PMID: 17289871
NCCN Guidelines Insights: Breast Cancer, Version 3.2018.
Matthew P Goetz, William J Gradishar, +30 authors, Rashmi Kumar.
J Natl Compr Canc Netw, 2019 Feb 23; 17(2). PMID: 30787125
Highly Cited.
Use of new molecular tests for melanoma by pigmented-lesion experts.
Amir Varedi, Laura J Gardner, +6 authors, Douglas Grossman.
J Am Acad Dermatol, 2019 Aug 16; 82(1). PMID: 31415835
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.
Lyndsay Harris, Herbert Fritsche, +7 authors, American Society of Clinical Oncology.
J Clin Oncol, 2007 Oct 24; 25(33). PMID: 17954709
Highly Cited. Review.
Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas.
Amanda Pfaff Smith, Keith Hoek, Dorothea Becker.
Cancer Biol Ther, 2005 Oct 28; 4(9). PMID: 16251803
Clinical Performance and Management Outcomes with the DecisionDx-UM Gene Expression Profile Test in a Prospective Multicenter Study.
Kristen Meldi Plasseraud, Robert W Cook, +8 authors, Thomas M Aaberg.
J Oncol, 2016 Jul 23; 2016. PMID: 27446211    Free PMC article.
Early outcome of a 31-gene expression profile test in 86 AJCC stage IB-II melanoma patients. A prospective multicentre cohort study.
S Podlipnik, C Carrera, +10 authors, S Puig.
J Eur Acad Dermatol Venereol, 2019 Feb 01; 33(5). PMID: 30702163    Free PMC article.
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer.
Thomas Reinert, Tenna Vesterman Henriksen, +35 authors, Claus Lindbjerg Andersen.
JAMA Oncol, 2019 May 10;. PMID: 31070691    Free PMC article.
Highly Cited.
Current controversies in early-stage melanoma: Questions on management and surveillance.
Marki E Klapperich, Glen M Bowen, Douglas Grossman.
J Am Acad Dermatol, 2018 Dec 17; 80(1). PMID: 30553299
Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma.
Pedram Gerami, Robert W Cook, +13 authors, John F Stone.
Clin Cancer Res, 2015 Jan 08; 21(1). PMID: 25564571
New NCCN Guidelines for Uveal Melanoma and Treatment of Recurrent or Progressive Distant Metastatic Melanoma.
Christopher A Barker, April K Salama.
J Natl Compr Canc Netw, 2018 May 23; 16(5S). PMID: 29784747
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Soonmyung Paik, Gong Tang, +11 authors, Norman Wolmark.
J Clin Oncol, 2006 May 25; 24(23). PMID: 16720680
Highly Cited.
Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients.
Jonathan S Zager, Brian R Gastman, +20 authors, Pedram Gerami.
BMC Cancer, 2018 Feb 07; 18(1). PMID: 29402264    Free PMC article.
Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma: a meta-analysis.
Matias E Valsecchi, Damian Silbermins, +2 authors, Gary H Lyman.
J Clin Oncol, 2011 Mar 09; 29(11). PMID: 21383281
The gene expression signatures of melanoma progression.
Christopher Haqq, Mehdi Nosrati, +11 authors, Mohammed Kashani-Sabet.
Proc Natl Acad Sci U S A, 2005 Apr 19; 102(17). PMID: 15833814    Free PMC article.
Highly Cited.
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
Joseph A Sparano, Robert J Gray, +27 authors, George W Sledge.
N Engl J Med, 2018 Jun 05; 379(2). PMID: 29860917    Free PMC article.
Highly Cited.
Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma.
Emil Christensen, Karin Birkenkamp-Demtröder, +31 authors, Lars Dyrskjøt.
J Clin Oncol, 2019 May 07; 37(18). PMID: 31059311
Highly Cited.
Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial.
C M Balch, M M Urist, +7 authors, R Barnhill.
Ann Surg, 1993 Sep 01; 218(3). PMID: 8373269    Free PMC article.
Clinical validation of a prognostic 11-gene expression profiling score in prospectively collected FFPE tissue of patients with AJCC v8 stage II cutaneous melanoma.
Teresa M S Amaral, Marie-Christine Hoffmann, +4 authors, Claus Garbe.
Eur J Cancer, 2019 Dec 16; 125. PMID: 31838403
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.
Mark B Faries, John F Thompson, +56 authors, Robert M Elashoff.
N Engl J Med, 2017 Jun 08; 376(23). PMID: 28591523    Free PMC article.
Highly Cited.
Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
Daniel G Coit, John A Thompson, +27 authors, Anita M Engh.
J Natl Compr Canc Netw, 2019 Apr 09; 17(4). PMID: 30959471
Highly Cited.
Breast cancer. Clinical practice guidelines in oncology.
Robert W Carlson, D Craig Allred, +26 authors, NCCN Breast Cancer Clinical Practice Guidelines Panel.
J Natl Compr Canc Netw, 2009 Feb 10; 7(2). PMID: 19200416
Highly Cited. Review.
Current clinical practice: differential management of uveal melanoma in the era of molecular tumor analyses.
Thomas M Aaberg, Robert W Cook, +3 authors, John O Mason.
Clin Ophthalmol, 2015 Jan 15; 8. PMID: 25587217    Free PMC article.
Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence.
Raoul Charles Coombes, Karen Page, +36 authors, Jaqueline A Shaw.
Clin Cancer Res, 2019 Apr 18; 25(14). PMID: 30992300
Highly Cited.
Guidelines of care for the management of primary cutaneous melanoma.
Susan M Swetter, Hensin Tsao, +13 authors, Toyin Lamina.
J Am Acad Dermatol, 2018 Nov 06; 80(1). PMID: 30392755
Use of a prognostic gene expression profile test for T1 cutaneous melanoma: Will it help or harm patients?
Michael A Marchetti, Edmund K Bartlett, Stephen W Dusza, Christopher K Bichakjian.
J Am Acad Dermatol, 2018 Dec 27; 80(6). PMID: 30586612
Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma.
Michael D Onken, Lori A Worley, +18 authors, J William Harbour.
Ophthalmology, 2012 Apr 24; 119(8). PMID: 22521086    Free PMC article.
Highly Cited.
Association between Tumor Regression Rate and Gene Expression Profile after Iodine 125 Plaque Radiotherapy for Uveal Melanoma.
Prithvi Mruthyunjaya, Michael I Seider, +2 authors, Ocular Oncology Study Consortium.
Ophthalmology, 2017 May 28; 124(10). PMID: 28549517
Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
Jeffrey E Gershenwald, Richard A Scolyer, +13 authors, for members of the American Joint Committee on Cancer Melanoma Expert Panel and the International Melanoma Database and Discovery Platform.
CA Cancer J Clin, 2017 Oct 14; 67(6). PMID: 29028110    Free PMC article.
Highly Cited.
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.
Christopher Abbosh, Nicolai J Birkbak, +103 authors, Charles Swanton.
Nature, 2017 Apr 27; 545(7655). PMID: 28445469    Free PMC article.
Highly Cited.
Identification of patients at risk of metastasis using a prognostic 31-gene expression profile in subpopulations of melanoma patients with favorable outcomes by standard criteria.
Brian R Gastman, Pedram Gerami, +3 authors, John T Vetto.
J Am Acad Dermatol, 2018 Aug 07; 80(1). PMID: 30081113
Prospective validation of the prognostic 31-gene expression profiling test in primary cutaneous melanoma.
Jennifer Keller, Theresa L Schwartz, +4 authors, Eddy C Hsueh.
Cancer Med, 2019 Apr 06; 8(5). PMID: 30950242    Free PMC article.
Tumor Cell Adhesion As a Risk Factor for Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma.
Alexander Meves, Ekaterina Nikolova, +10 authors, Vera J Suman.
J Clin Oncol, 2015 Jul 08; 33(23). PMID: 26150443    Free PMC article.
A nine-gene signature predicting clinical outcome in cutaneous melanoma.
G Brunner, M Reitz, +4 authors, J Atzpodien.
J Cancer Res Clin Oncol, 2012 Oct 12; 139(2). PMID: 23052696
Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group.
D L Morton, J F Thompson, +10 authors, A J Cochran.
Ann Surg, 1999 Oct 16; 230(4). PMID: 10522715    Free PMC article.
Highly Cited.
The role of integrins in melanoma: a review.
Suzette M Arias-Mejias, Katerina Y Warda, +3 authors, Alexander Meves.
Int J Dermatol, 2020 Mar 12; 59(5). PMID: 32157692    Free PMC article.
20/20 in 2020: seeking clarity on the management of stage III melanoma in a rapidly changing treatment environment.
Sanjay Chandrasekaran, David H Lawson.
Ann Transl Med, 2020 Jul 11; 8(12). PMID: 32647701    Free PMC article.
Primary cilia: putting a sensor on the underlying melanocytic tumor cell state.
Ursula E Lang.
Melanoma Manag, 2020 Aug 22; 7(2). PMID: 32821372    Free PMC article.
Cellular and Molecular Aspects of Anti-Melanoma Effect of Minocycline-A Study of Cytotoxicity and Apoptosis on Human Melanotic Melanoma Cells.
Jakub Rok, Zuzanna Rzepka, +2 authors, Dorota Wrześniok.
Int J Mol Sci, 2020 Sep 25; 21(18). PMID: 32967177    Free PMC article.
β3 integrin immunohistochemistry as a method to predict sentinel lymph node status in patients with primary cutaneous melanoma.
Enrica Quattrocchi, Sindhuja Sominidi-Damodaran, Dennis H Murphree, Alexander Meves.
Int J Dermatol, 2020 Aug 11; 59(10). PMID: 32772371    Free PMC article.